Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Asthma | 42 | 2023 | 871 | 5.320 |
Why?
|
Hypersensitivity | 19 | 2023 | 216 | 4.230 |
Why?
|
Peptide Hydrolases | 12 | 2019 | 256 | 3.250 |
Why?
|
Mycoses | 10 | 2023 | 386 | 3.220 |
Why?
|
Th2 Cells | 30 | 2021 | 257 | 2.710 |
Why?
|
Emphysema | 11 | 2022 | 87 | 2.710 |
Why?
|
Allergens | 17 | 2018 | 247 | 2.460 |
Why?
|
Respiratory Hypersensitivity | 9 | 2019 | 51 | 2.290 |
Why?
|
Th17 Cells | 9 | 2021 | 162 | 2.250 |
Why?
|
Immunity, Innate | 18 | 2020 | 677 | 2.130 |
Why?
|
Lung | 39 | 2023 | 3151 | 2.080 |
Why?
|
Sinusitis | 8 | 2023 | 131 | 1.860 |
Why?
|
Fibrinogen | 5 | 2019 | 205 | 1.830 |
Why?
|
Toll-Like Receptor 4 | 6 | 2023 | 203 | 1.760 |
Why?
|
Pulmonary Emphysema | 7 | 2022 | 145 | 1.640 |
Why?
|
Interleukin-13 | 18 | 2018 | 135 | 1.610 |
Why?
|
Fungal Proteins | 6 | 2023 | 254 | 1.610 |
Why?
|
CD11b Antigen | 2 | 2023 | 66 | 1.600 |
Why?
|
Aspergillosis, Allergic Bronchopulmonary | 5 | 2021 | 34 | 1.580 |
Why?
|
Viral Vaccines | 4 | 2020 | 304 | 1.510 |
Why?
|
Fungi | 6 | 2023 | 145 | 1.500 |
Why?
|
Aspergillus niger | 6 | 2021 | 25 | 1.440 |
Why?
|
Respiratory Mucosa | 10 | 2020 | 206 | 1.290 |
Why?
|
Lung Diseases, Fungal | 2 | 2019 | 124 | 1.240 |
Why?
|
Rhinitis | 5 | 2021 | 37 | 1.200 |
Why?
|
Respiratory System | 8 | 2023 | 125 | 1.180 |
Why?
|
T-Lymphocytes, Helper-Inducer | 6 | 2021 | 212 | 1.170 |
Why?
|
Cytokines | 23 | 2020 | 2809 | 1.130 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 10 | 2022 | 1021 | 1.120 |
Why?
|
Candida albicans | 3 | 2023 | 175 | 1.120 |
Why?
|
Animals | 102 | 2023 | 59536 | 1.110 |
Why?
|
Bronchial Hyperreactivity | 9 | 2021 | 53 | 1.100 |
Why?
|
Th1 Cells | 7 | 2012 | 250 | 1.090 |
Why?
|
Inflammation | 16 | 2023 | 2522 | 1.070 |
Why?
|
Antifungal Agents | 3 | 2021 | 834 | 1.050 |
Why?
|
Betacoronavirus | 3 | 2020 | 527 | 1.030 |
Why?
|
Mice | 80 | 2023 | 34495 | 1.010 |
Why?
|
Bronchoalveolar Lavage Fluid | 17 | 2018 | 254 | 1.000 |
Why?
|
STAT6 Transcription Factor | 8 | 2022 | 67 | 1.000 |
Why?
|
Microglia | 2 | 2023 | 164 | 0.990 |
Why?
|
Mice, Inbred C57BL | 43 | 2021 | 6942 | 0.980 |
Why?
|
Immunity, Cellular | 8 | 2020 | 419 | 0.980 |
Why?
|
Coronavirus Infections | 4 | 2020 | 651 | 0.960 |
Why?
|
Disease Models, Animal | 32 | 2021 | 7222 | 0.960 |
Why?
|
Lung Diseases | 6 | 2018 | 717 | 0.950 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 715 | 0.930 |
Why?
|
Immunity | 5 | 2021 | 342 | 0.910 |
Why?
|
Cigarette Smoking | 4 | 2019 | 88 | 0.890 |
Why?
|
Disease Susceptibility | 3 | 2021 | 538 | 0.860 |
Why?
|
T-Lymphocyte Subsets | 3 | 2021 | 582 | 0.850 |
Why?
|
Interleukin-4 | 19 | 2018 | 284 | 0.850 |
Why?
|
Aspergillus | 6 | 2022 | 149 | 0.840 |
Why?
|
Mice, Knockout | 28 | 2019 | 5710 | 0.790 |
Why?
|
Pandemics | 3 | 2020 | 1559 | 0.790 |
Why?
|
Lung Diseases, Parasitic | 2 | 2020 | 14 | 0.780 |
Why?
|
Candidiasis | 2 | 2021 | 262 | 0.770 |
Why?
|
Helminthiasis | 2 | 2020 | 67 | 0.760 |
Why?
|
Host-Parasite Interactions | 1 | 2020 | 62 | 0.760 |
Why?
|
Leishmaniasis, Cutaneous | 6 | 2013 | 46 | 0.750 |
Why?
|
Helminths | 1 | 2020 | 37 | 0.740 |
Why?
|
DNA Cleavage | 2 | 2017 | 6 | 0.730 |
Why?
|
Leishmania major | 5 | 2013 | 21 | 0.730 |
Why?
|
CD4-Positive T-Lymphocytes | 10 | 2019 | 1033 | 0.720 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 82 | 0.720 |
Why?
|
Host-Pathogen Interactions | 2 | 2021 | 314 | 0.690 |
Why?
|
Antigen-Presenting Cells | 6 | 2019 | 284 | 0.670 |
Why?
|
Cerebrum | 1 | 2019 | 44 | 0.670 |
Why?
|
Lung Diseases, Obstructive | 1 | 2018 | 46 | 0.660 |
Why?
|
Matrix Metalloproteinase 2 | 5 | 2011 | 256 | 0.650 |
Why?
|
Adaptive Immunity | 5 | 2022 | 149 | 0.650 |
Why?
|
Pulmonary Aspergillosis | 2 | 2021 | 31 | 0.650 |
Why?
|
Candidemia | 1 | 2019 | 60 | 0.630 |
Why?
|
Mice, Inbred BALB C | 19 | 2018 | 2314 | 0.610 |
Why?
|
Blood Platelets | 1 | 2021 | 731 | 0.570 |
Why?
|
Dust | 3 | 2011 | 39 | 0.560 |
Why?
|
Sputum | 2 | 2018 | 141 | 0.550 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2020 | 427 | 0.550 |
Why?
|
MicroRNAs | 4 | 2015 | 2947 | 0.550 |
Why?
|
Memory Disorders | 1 | 2019 | 295 | 0.550 |
Why?
|
Bronchodilator Agents | 1 | 2018 | 219 | 0.550 |
Why?
|
CD11a Antigen | 2 | 2013 | 15 | 0.540 |
Why?
|
Peptidomimetics | 1 | 2015 | 26 | 0.540 |
Why?
|
Smoking | 12 | 2019 | 2440 | 0.540 |
Why?
|
Aspergillus fumigatus | 6 | 2019 | 135 | 0.540 |
Why?
|
Exercise Test | 3 | 2015 | 312 | 0.530 |
Why?
|
Autoimmunity | 6 | 2019 | 263 | 0.530 |
Why?
|
Airway Obstruction | 5 | 2011 | 261 | 0.520 |
Why?
|
Orthomyxoviridae Infections | 2 | 2017 | 72 | 0.520 |
Why?
|
Respiratory Tract Infections | 1 | 2019 | 437 | 0.510 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2015 | 106 | 0.500 |
Why?
|
Humans | 91 | 2024 | 261506 | 0.500 |
Why?
|
Soot | 3 | 2022 | 14 | 0.500 |
Why?
|
Bronchitis | 2 | 2012 | 38 | 0.490 |
Why?
|
Anti-Asthmatic Agents | 1 | 2015 | 118 | 0.480 |
Why?
|
Influenza Vaccines | 4 | 2020 | 635 | 0.480 |
Why?
|
Matrix Metalloproteinase 9 | 5 | 2019 | 360 | 0.480 |
Why?
|
CD18 Antigens | 2 | 2004 | 83 | 0.470 |
Why?
|
Immunity, Mucosal | 2 | 2011 | 108 | 0.470 |
Why?
|
Eosinophils | 5 | 2021 | 162 | 0.460 |
Why?
|
Dendritic Cells | 10 | 2022 | 1085 | 0.450 |
Why?
|
Interleukin-5 | 7 | 2018 | 73 | 0.450 |
Why?
|
Status Asthmaticus | 2 | 2012 | 21 | 0.450 |
Why?
|
Tracheitis | 1 | 2012 | 21 | 0.450 |
Why?
|
Interleukin-17 | 6 | 2018 | 250 | 0.440 |
Why?
|
RNA, Antisense | 1 | 2012 | 69 | 0.440 |
Why?
|
Argonaute Proteins | 1 | 2012 | 40 | 0.440 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2012 | 65 | 0.440 |
Why?
|
T-Lymphocytes | 12 | 2017 | 3869 | 0.430 |
Why?
|
Chemokines, CC | 4 | 2005 | 36 | 0.430 |
Why?
|
Lymphocyte Activation | 11 | 2021 | 1688 | 0.430 |
Why?
|
Biomarkers | 6 | 2020 | 5047 | 0.430 |
Why?
|
Inflammation Mediators | 3 | 2020 | 423 | 0.430 |
Why?
|
Bronchoalveolar Lavage | 2 | 2010 | 53 | 0.430 |
Why?
|
Aspergillus oryzae | 2 | 2013 | 8 | 0.430 |
Why?
|
Nasal Polyps | 4 | 2019 | 27 | 0.420 |
Why?
|
Elastin | 3 | 2019 | 49 | 0.420 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2012 | 68 | 0.410 |
Why?
|
Gene Expression Regulation | 8 | 2020 | 4053 | 0.400 |
Why?
|
Spores, Fungal | 3 | 2021 | 32 | 0.400 |
Why?
|
CD28 Antigens | 2 | 2006 | 202 | 0.390 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2012 | 163 | 0.390 |
Why?
|
Dermatitis, Atopic | 1 | 2011 | 47 | 0.380 |
Why?
|
HIV | 1 | 2012 | 229 | 0.380 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2012 | 291 | 0.370 |
Why?
|
Nanoparticles | 2 | 2015 | 554 | 0.360 |
Why?
|
Interferon-gamma | 13 | 2019 | 1144 | 0.360 |
Why?
|
Pneumonia | 4 | 2011 | 751 | 0.360 |
Why?
|
Interleukin-10 | 6 | 2019 | 478 | 0.350 |
Why?
|
Epithelial Cells | 6 | 2021 | 1818 | 0.350 |
Why?
|
Amyloid beta-Peptides | 2 | 2023 | 246 | 0.350 |
Why?
|
Mycosis Fungoides | 1 | 2012 | 320 | 0.350 |
Why?
|
Bronchi | 4 | 2021 | 326 | 0.350 |
Why?
|
Interleukins | 4 | 2019 | 325 | 0.340 |
Why?
|
Respiratory Function Tests | 3 | 2011 | 318 | 0.340 |
Why?
|
B-Lymphocytes | 7 | 2024 | 1294 | 0.340 |
Why?
|
Immunoglobulin E | 4 | 2014 | 163 | 0.340 |
Why?
|
Adjuvants, Immunologic | 4 | 2020 | 657 | 0.330 |
Why?
|
Signal Transduction | 12 | 2019 | 11965 | 0.330 |
Why?
|
Flow Cytometry | 6 | 2014 | 3033 | 0.330 |
Why?
|
Hypersensitivity, Immediate | 1 | 2008 | 25 | 0.320 |
Why?
|
Cell Differentiation | 11 | 2019 | 4078 | 0.320 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2019 | 1538 | 0.310 |
Why?
|
Severity of Illness Index | 6 | 2022 | 4320 | 0.310 |
Why?
|
Pulmonary Alveoli | 1 | 2009 | 208 | 0.310 |
Why?
|
Cell Movement | 5 | 2018 | 2466 | 0.310 |
Why?
|
Repressor Proteins | 1 | 2015 | 1664 | 0.310 |
Why?
|
Ovalbumin | 9 | 2018 | 254 | 0.290 |
Why?
|
Smoke | 4 | 2019 | 60 | 0.290 |
Why?
|
Integrins | 1 | 2008 | 262 | 0.290 |
Why?
|
Leukopenia | 1 | 2006 | 151 | 0.280 |
Why?
|
Chemotaxis | 2 | 2003 | 138 | 0.280 |
Why?
|
Cell Separation | 2 | 2011 | 612 | 0.270 |
Why?
|
Cells, Cultured | 13 | 2019 | 5637 | 0.270 |
Why?
|
Receptors, Prostaglandin E | 1 | 2005 | 14 | 0.270 |
Why?
|
Chronic Disease | 6 | 2023 | 1819 | 0.260 |
Why?
|
Macrophages, Alveolar | 4 | 2023 | 67 | 0.260 |
Why?
|
Influenza, Human | 3 | 2020 | 925 | 0.260 |
Why?
|
Interleukin-1 | 2 | 2017 | 461 | 0.260 |
Why?
|
Mathematical Computing | 1 | 2004 | 22 | 0.260 |
Why?
|
T-Lymphocytes, Regulatory | 4 | 2019 | 673 | 0.250 |
Why?
|
Mucus | 3 | 2018 | 119 | 0.250 |
Why?
|
Bronchoconstriction | 3 | 2021 | 22 | 0.250 |
Why?
|
Neovascularization, Physiologic | 2 | 2017 | 345 | 0.240 |
Why?
|
Antigens, Fungal | 5 | 2014 | 40 | 0.240 |
Why?
|
Receptors, Immunologic | 1 | 2006 | 309 | 0.240 |
Why?
|
Proteoglycans | 1 | 2005 | 259 | 0.240 |
Why?
|
Software | 2 | 2007 | 1321 | 0.220 |
Why?
|
Immune Tolerance | 5 | 2019 | 403 | 0.220 |
Why?
|
Body Fluids | 1 | 2024 | 125 | 0.220 |
Why?
|
NF-kappa B | 3 | 2019 | 1549 | 0.220 |
Why?
|
Goblet Cells | 3 | 2015 | 135 | 0.220 |
Why?
|
Antibodies, Viral | 5 | 2020 | 1320 | 0.220 |
Why?
|
Immune System Diseases | 1 | 2003 | 65 | 0.210 |
Why?
|
Immunologic Memory | 3 | 2014 | 374 | 0.210 |
Why?
|
Data Interpretation, Statistical | 1 | 2004 | 482 | 0.210 |
Why?
|
Immunologic Factors | 1 | 2006 | 649 | 0.210 |
Why?
|
Alveolitis, Extrinsic Allergic | 1 | 2021 | 15 | 0.210 |
Why?
|
Arachis | 1 | 2022 | 65 | 0.200 |
Why?
|
Interleukin-33 | 2 | 2019 | 23 | 0.200 |
Why?
|
Communicable Diseases | 1 | 2004 | 193 | 0.200 |
Why?
|
Receptors, Complement | 2 | 2014 | 48 | 0.200 |
Why?
|
Proteomics | 2 | 2009 | 1380 | 0.200 |
Why?
|
Computers | 1 | 2021 | 141 | 0.200 |
Why?
|
Heart Diseases | 1 | 2007 | 732 | 0.200 |
Why?
|
Conjunctiva | 2 | 2015 | 250 | 0.200 |
Why?
|
Peanut Hypersensitivity | 1 | 2022 | 67 | 0.190 |
Why?
|
Life Cycle Stages | 1 | 2020 | 27 | 0.190 |
Why?
|
Female | 34 | 2024 | 141928 | 0.190 |
Why?
|
Tobacco Products | 2 | 2019 | 120 | 0.190 |
Why?
|
Interleukin-1beta | 2 | 2019 | 300 | 0.190 |
Why?
|
Antibodies, Neutralizing | 3 | 2020 | 541 | 0.190 |
Why?
|
Influenza A Virus, H7N7 Subtype | 1 | 2020 | 14 | 0.190 |
Why?
|
Influenza in Birds | 1 | 2020 | 26 | 0.180 |
Why?
|
Neutrophils | 3 | 2019 | 835 | 0.180 |
Why?
|
Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 28 | 0.180 |
Why?
|
Membrane Glycoproteins | 1 | 2005 | 1073 | 0.180 |
Why?
|
Influenza A Virus, H7N9 Subtype | 1 | 2020 | 25 | 0.180 |
Why?
|
Glycoproteins | 1 | 2004 | 747 | 0.180 |
Why?
|
Eosinophilia | 1 | 2022 | 176 | 0.180 |
Why?
|
Transcription Factor AP-1 | 2 | 2015 | 246 | 0.180 |
Why?
|
Clinical Trials as Topic | 3 | 2020 | 3719 | 0.180 |
Why?
|
Chemokines | 2 | 2014 | 314 | 0.180 |
Why?
|
Complement C1q | 1 | 2019 | 28 | 0.170 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2020 | 171 | 0.170 |
Why?
|
Peptide Fragments | 3 | 2019 | 1271 | 0.170 |
Why?
|
HIV Infections | 1 | 2012 | 2134 | 0.170 |
Why?
|
Lipopolysaccharides | 1 | 2021 | 558 | 0.170 |
Why?
|
Protein Binding | 3 | 2019 | 3438 | 0.170 |
Why?
|
Organ Specificity | 1 | 2020 | 699 | 0.170 |
Why?
|
Immunomodulation | 1 | 2020 | 242 | 0.170 |
Why?
|
src Homology Domains | 2 | 2018 | 124 | 0.170 |
Why?
|
Human Umbilical Vein Endothelial Cells | 2 | 2017 | 164 | 0.170 |
Why?
|
Leukocytes, Mononuclear | 3 | 2015 | 709 | 0.170 |
Why?
|
Electronic Nicotine Delivery Systems | 1 | 2019 | 63 | 0.160 |
Why?
|
Peak Expiratory Flow Rate | 1 | 2018 | 23 | 0.160 |
Why?
|
Research Design | 1 | 2006 | 1544 | 0.160 |
Why?
|
Ascariasis | 1 | 2018 | 65 | 0.160 |
Why?
|
Sarcoidosis | 1 | 2019 | 112 | 0.160 |
Why?
|
Models, Theoretical | 1 | 2022 | 785 | 0.160 |
Why?
|
Plethysmography | 1 | 2018 | 31 | 0.160 |
Why?
|
RNA, Messenger | 8 | 2015 | 6150 | 0.160 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2019 | 137 | 0.160 |
Why?
|
Protein Subunits | 1 | 2019 | 274 | 0.160 |
Why?
|
Lymphocytes | 2 | 2020 | 1234 | 0.160 |
Why?
|
Protein Domains | 1 | 2019 | 314 | 0.150 |
Why?
|
Drug Design | 1 | 2020 | 375 | 0.150 |
Why?
|
Bronchial Provocation Tests | 2 | 2010 | 18 | 0.150 |
Why?
|
STAT5 Transcription Factor | 1 | 2018 | 214 | 0.150 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2017 | 166 | 0.150 |
Why?
|
Macrophages | 4 | 2022 | 1304 | 0.150 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2019 | 362 | 0.150 |
Why?
|
Antibodies, Monoclonal | 2 | 2006 | 4367 | 0.150 |
Why?
|
Leukocyte Count | 1 | 2018 | 684 | 0.140 |
Why?
|
Complement C3a | 3 | 2015 | 18 | 0.140 |
Why?
|
Cell Adhesion | 2 | 2013 | 1008 | 0.140 |
Why?
|
Cystic Fibrosis | 1 | 2019 | 264 | 0.140 |
Why?
|
RNA, Small Interfering | 2 | 2012 | 2216 | 0.140 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 169 | 0.140 |
Why?
|
Coccidioidomycosis | 1 | 1996 | 32 | 0.140 |
Why?
|
Extracellular Matrix Proteins | 1 | 2018 | 315 | 0.140 |
Why?
|
Influenza A virus | 1 | 2017 | 270 | 0.140 |
Why?
|
Salmeterol Xinafoate | 1 | 2015 | 22 | 0.140 |
Why?
|
Monocytes | 1 | 2020 | 788 | 0.140 |
Why?
|
Adoptive Transfer | 4 | 2019 | 446 | 0.140 |
Why?
|
Peripheral Tolerance | 1 | 2015 | 4 | 0.140 |
Why?
|
beta-Arrestins | 1 | 2015 | 44 | 0.140 |
Why?
|
Lipid Metabolism | 1 | 2019 | 483 | 0.140 |
Why?
|
Arrestins | 1 | 2015 | 46 | 0.140 |
Why?
|
Retinal Neovascularization | 1 | 2015 | 20 | 0.140 |
Why?
|
Propanolamines | 1 | 2015 | 44 | 0.140 |
Why?
|
Alzheimer Disease | 1 | 2023 | 855 | 0.140 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 1998 | 238 | 0.140 |
Why?
|
Lung Neoplasms | 4 | 2023 | 11538 | 0.140 |
Why?
|
Phosphopeptides | 1 | 2015 | 65 | 0.130 |
Why?
|
Formoterol Fumarate | 1 | 2015 | 51 | 0.130 |
Why?
|
Immunization, Secondary | 1 | 2015 | 110 | 0.130 |
Why?
|
Chemokine CCL11 | 3 | 2005 | 18 | 0.130 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2019 | 488 | 0.130 |
Why?
|
Albuterol | 1 | 2015 | 76 | 0.130 |
Why?
|
Carbazoles | 1 | 2015 | 87 | 0.130 |
Why?
|
Astrocytes | 1 | 2019 | 368 | 0.130 |
Why?
|
Interleukin-6 | 1 | 2020 | 1038 | 0.130 |
Why?
|
Environmental Exposure | 1 | 2018 | 288 | 0.130 |
Why?
|
Cross-Priming | 1 | 2015 | 39 | 0.130 |
Why?
|
Autoantibodies | 1 | 2019 | 576 | 0.130 |
Why?
|
Silicon | 1 | 2015 | 48 | 0.130 |
Why?
|
Mucin 5AC | 1 | 2015 | 75 | 0.130 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2015 | 106 | 0.130 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2015 | 123 | 0.130 |
Why?
|
Osteopontin | 2 | 2014 | 148 | 0.130 |
Why?
|
Retinopathy of Prematurity | 1 | 2015 | 88 | 0.130 |
Why?
|
Leishmaniasis | 1 | 1994 | 24 | 0.130 |
Why?
|
Microspheres | 1 | 2015 | 210 | 0.130 |
Why?
|
Antibodies, Fungal | 1 | 2014 | 16 | 0.130 |
Why?
|
Leukotrienes | 1 | 2014 | 14 | 0.120 |
Why?
|
B7-1 Antigen | 1 | 1994 | 88 | 0.120 |
Why?
|
Homeostasis | 3 | 2019 | 950 | 0.120 |
Why?
|
Respiratory Mechanics | 2 | 2007 | 173 | 0.120 |
Why?
|
Adaptor Proteins, Vesicular Transport | 2 | 2015 | 94 | 0.120 |
Why?
|
Adult | 12 | 2021 | 77950 | 0.120 |
Why?
|
Intestines | 1 | 2019 | 686 | 0.120 |
Why?
|
Kv1.3 Potassium Channel | 1 | 2014 | 36 | 0.120 |
Why?
|
Cell Line | 5 | 2019 | 5114 | 0.120 |
Why?
|
Dose-Response Relationship, Immunologic | 2 | 2011 | 182 | 0.120 |
Why?
|
Interferon Type I | 1 | 2015 | 250 | 0.120 |
Why?
|
Disease Progression | 7 | 2024 | 6682 | 0.120 |
Why?
|
Male | 20 | 2022 | 123000 | 0.120 |
Why?
|
Th1-Th2 Balance | 1 | 2013 | 12 | 0.120 |
Why?
|
Chemokine CCL17 | 2 | 2004 | 14 | 0.120 |
Why?
|
Chemokine CCL7 | 2 | 2004 | 12 | 0.120 |
Why?
|
Monocyte Chemoattractant Proteins | 2 | 2004 | 17 | 0.120 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2013 | 60 | 0.110 |
Why?
|
Histone Deacetylases | 1 | 2015 | 365 | 0.110 |
Why?
|
Macrophage Activation | 1 | 2013 | 148 | 0.110 |
Why?
|
STAT Transcription Factors | 1 | 2013 | 79 | 0.110 |
Why?
|
Thiazolidinediones | 1 | 2014 | 148 | 0.110 |
Why?
|
PPAR gamma | 1 | 2014 | 229 | 0.110 |
Why?
|
Virus Replication | 2 | 2021 | 709 | 0.110 |
Why?
|
Tuberculosis | 1 | 2019 | 548 | 0.110 |
Why?
|
RNA | 3 | 2013 | 1013 | 0.110 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2019 | 595 | 0.110 |
Why?
|
RNA Precursors | 1 | 2012 | 137 | 0.110 |
Why?
|
Homeodomain Proteins | 3 | 2011 | 1143 | 0.100 |
Why?
|
Chitin | 1 | 2011 | 5 | 0.100 |
Why?
|
Case-Control Studies | 5 | 2019 | 6100 | 0.100 |
Why?
|
Pulmonary Eosinophilia | 1 | 2011 | 13 | 0.100 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2011 | 93 | 0.100 |
Why?
|
Molecular Sequence Data | 8 | 2008 | 6089 | 0.100 |
Why?
|
Transforming Growth Factor beta | 1 | 2017 | 1130 | 0.100 |
Why?
|
Tyrosine | 2 | 2015 | 498 | 0.100 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2012 | 518 | 0.100 |
Why?
|
Dry Eye Syndromes | 1 | 2015 | 286 | 0.100 |
Why?
|
beta-N-Acetylhexosaminidases | 2 | 2008 | 19 | 0.100 |
Why?
|
Calgranulin B | 2 | 2008 | 22 | 0.100 |
Why?
|
Immunoconjugates | 1 | 1994 | 279 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2004 | 1489 | 0.100 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 2 | 2009 | 212 | 0.100 |
Why?
|
Retrospective Studies | 3 | 2021 | 37905 | 0.100 |
Why?
|
Mice, Inbred CBA | 1 | 2010 | 78 | 0.100 |
Why?
|
Lectins | 2 | 2008 | 151 | 0.100 |
Why?
|
Ligands | 1 | 2013 | 995 | 0.100 |
Why?
|
Gene Duplication | 1 | 2012 | 421 | 0.090 |
Why?
|
Phenotype | 5 | 2024 | 6295 | 0.090 |
Why?
|
Rhinovirus | 1 | 2010 | 94 | 0.090 |
Why?
|
Picornaviridae Infections | 1 | 2010 | 57 | 0.090 |
Why?
|
Killer Cells, Natural | 2 | 2010 | 904 | 0.090 |
Why?
|
Vaccines, Subunit | 1 | 2010 | 124 | 0.090 |
Why?
|
Leishmania braziliensis | 1 | 2009 | 3 | 0.090 |
Why?
|
Forecasting | 2 | 2005 | 694 | 0.090 |
Why?
|
Gene Deletion | 2 | 2005 | 1442 | 0.090 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2009 | 32 | 0.090 |
Why?
|
Cell Migration Inhibition | 2 | 2006 | 16 | 0.090 |
Why?
|
Pneumococcal Infections | 1 | 2011 | 241 | 0.080 |
Why?
|
Streptococcus pneumoniae | 1 | 2011 | 330 | 0.080 |
Why?
|
Cysteine Endopeptidases | 1 | 2010 | 251 | 0.080 |
Why?
|
Airway Resistance | 2 | 2006 | 42 | 0.080 |
Why?
|
Gene Expression | 3 | 2015 | 3570 | 0.080 |
Why?
|
Toll-Like Receptor 2 | 1 | 2009 | 87 | 0.080 |
Why?
|
Dermatitis | 1 | 2009 | 60 | 0.080 |
Why?
|
Peritonitis | 1 | 2009 | 89 | 0.080 |
Why?
|
DNA, Complementary | 3 | 1994 | 869 | 0.080 |
Why?
|
Interleukin-12 Subunit p40 | 1 | 2008 | 29 | 0.080 |
Why?
|
Aged | 9 | 2019 | 70117 | 0.080 |
Why?
|
Receptors, Interleukin | 3 | 2006 | 97 | 0.080 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2008 | 72 | 0.080 |
Why?
|
Anaerobic Threshold | 1 | 2007 | 11 | 0.080 |
Why?
|
Pulmonary Gas Exchange | 1 | 2007 | 41 | 0.080 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2009 | 155 | 0.080 |
Why?
|
RNA Editing | 1 | 2008 | 92 | 0.080 |
Why?
|
Brain Diseases | 1 | 2011 | 403 | 0.080 |
Why?
|
Middle Aged | 12 | 2019 | 86204 | 0.080 |
Why?
|
Autophagy | 1 | 2014 | 927 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2330 | 0.080 |
Why?
|
Subtraction Technique | 1 | 2008 | 141 | 0.080 |
Why?
|
Receptors, Interleukin-4 | 4 | 2015 | 22 | 0.080 |
Why?
|
Matrix Metalloproteinase 12 | 2 | 2019 | 18 | 0.080 |
Why?
|
Vaccines, Inactivated | 2 | 2020 | 175 | 0.080 |
Why?
|
Polymorphism, Genetic | 1 | 2013 | 1450 | 0.080 |
Why?
|
Integrin beta1 | 1 | 2008 | 126 | 0.080 |
Why?
|
Viral Proteins | 1 | 2010 | 435 | 0.080 |
Why?
|
Antibodies, Anti-Idiotypic | 2 | 2006 | 101 | 0.080 |
Why?
|
Matrix Metalloproteinases | 1 | 2008 | 143 | 0.080 |
Why?
|
Polystyrenes | 1 | 2006 | 32 | 0.070 |
Why?
|
Leukocyte Elastase | 2 | 2019 | 70 | 0.070 |
Why?
|
Dipeptidases | 2 | 2006 | 16 | 0.070 |
Why?
|
Leukotriene C4 | 1 | 2006 | 8 | 0.070 |
Why?
|
Mice, Inbred Strains | 1 | 2007 | 521 | 0.070 |
Why?
|
Arylsulfonates | 1 | 2006 | 3 | 0.070 |
Why?
|
Sulfonium Compounds | 1 | 2006 | 4 | 0.070 |
Why?
|
Tretinoin | 1 | 2009 | 623 | 0.070 |
Why?
|
Animal Experimentation | 1 | 2006 | 7 | 0.070 |
Why?
|
Fluorescence | 1 | 2006 | 195 | 0.070 |
Why?
|
Anti-Allergic Agents | 1 | 2006 | 23 | 0.070 |
Why?
|
Oxygen Consumption | 1 | 2007 | 401 | 0.070 |
Why?
|
Omalizumab | 1 | 2006 | 26 | 0.070 |
Why?
|
Transcription, Genetic | 2 | 2021 | 3154 | 0.070 |
Why?
|
Cell Proliferation | 5 | 2019 | 7226 | 0.070 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 2864 | 0.070 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5319 | 0.070 |
Why?
|
Polymerase Chain Reaction | 4 | 1996 | 3203 | 0.070 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2007 | 269 | 0.070 |
Why?
|
Receptors, Prostaglandin E, EP3 Subtype | 1 | 2005 | 11 | 0.070 |
Why?
|
Syndecans | 1 | 2005 | 27 | 0.070 |
Why?
|
Reference Values | 1 | 2007 | 1099 | 0.070 |
Why?
|
Transcriptome | 3 | 2021 | 1859 | 0.070 |
Why?
|
Syndecan-1 | 1 | 2005 | 52 | 0.070 |
Why?
|
Coculture Techniques | 2 | 2019 | 626 | 0.070 |
Why?
|
Multiple Organ Failure | 1 | 2006 | 177 | 0.060 |
Why?
|
Heparan Sulfate Proteoglycans | 1 | 2005 | 54 | 0.060 |
Why?
|
Antibodies, Monoclonal, Humanized | 2 | 2006 | 3251 | 0.060 |
Why?
|
Administration, Intranasal | 1 | 2005 | 190 | 0.060 |
Why?
|
Structure-Activity Relationship | 2 | 2018 | 931 | 0.060 |
Why?
|
Stroke Volume | 1 | 2007 | 577 | 0.060 |
Why?
|
Shock, Septic | 1 | 2006 | 181 | 0.060 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2018 | 503 | 0.060 |
Why?
|
Heart Rate | 1 | 2007 | 737 | 0.060 |
Why?
|
Dinoprostone | 1 | 2005 | 208 | 0.060 |
Why?
|
Blotting, Western | 2 | 2015 | 3536 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 1 | 2008 | 803 | 0.060 |
Why?
|
Leukotriene D4 | 1 | 2002 | 6 | 0.060 |
Why?
|
Base Sequence | 6 | 2008 | 4917 | 0.050 |
Why?
|
Proteome | 1 | 2006 | 561 | 0.050 |
Why?
|
Acute Disease | 1 | 2008 | 2422 | 0.050 |
Why?
|
Antibodies | 1 | 2006 | 838 | 0.050 |
Why?
|
Amino Acid Sequence | 2 | 2006 | 4233 | 0.050 |
Why?
|
Phagocytosis | 2 | 2015 | 260 | 0.050 |
Why?
|
Matrix Metalloproteinase Inhibitors | 1 | 2002 | 57 | 0.050 |
Why?
|
Troponin | 1 | 2022 | 92 | 0.050 |
Why?
|
Particulate Matter | 1 | 2022 | 86 | 0.050 |
Why?
|
Carbon | 1 | 2022 | 149 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2018 | 5437 | 0.050 |
Why?
|
Leukocytes | 1 | 2004 | 422 | 0.050 |
Why?
|
Endothelium | 1 | 2002 | 158 | 0.050 |
Why?
|
Inhalation Exposure | 1 | 2021 | 41 | 0.050 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 1487 | 0.050 |
Why?
|
Dipeptides | 1 | 2002 | 91 | 0.050 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 4314 | 0.050 |
Why?
|
Metalloendopeptidases | 1 | 2002 | 170 | 0.050 |
Why?
|
Desensitization, Immunologic | 1 | 2022 | 94 | 0.050 |
Why?
|
Chemotaxis, Leukocyte | 2 | 2014 | 157 | 0.050 |
Why?
|
Mice, SCID | 2 | 1996 | 1869 | 0.050 |
Why?
|
Neoplasms | 2 | 2019 | 15193 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2009 | 935 | 0.050 |
Why?
|
A549 Cells | 1 | 2021 | 124 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2003 | 639 | 0.050 |
Why?
|
Protease Inhibitors | 1 | 2002 | 210 | 0.050 |
Why?
|
Alum Compounds | 1 | 2020 | 42 | 0.050 |
Why?
|
Real-Time Polymerase Chain Reaction | 2 | 2015 | 1217 | 0.050 |
Why?
|
Creatinine | 1 | 2022 | 531 | 0.050 |
Why?
|
Receptors, IgE | 1 | 1999 | 39 | 0.050 |
Why?
|
Birds | 1 | 2020 | 92 | 0.040 |
Why?
|
Immunophenotyping | 2 | 2018 | 1681 | 0.040 |
Why?
|
Exercise | 1 | 2007 | 1183 | 0.040 |
Why?
|
Solvents | 1 | 2019 | 66 | 0.040 |
Why?
|
RNA, Viral | 1 | 2022 | 671 | 0.040 |
Why?
|
Intestinal Diseases, Parasitic | 1 | 1999 | 36 | 0.040 |
Why?
|
Receptor, PAR-2 | 1 | 2019 | 6 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2018 | 7789 | 0.040 |
Why?
|
Ascaris | 1 | 2018 | 9 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2019 | 252 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2014 | 4143 | 0.040 |
Why?
|
Nasal Mucosa | 1 | 2019 | 94 | 0.040 |
Why?
|
Vital Capacity | 1 | 2019 | 131 | 0.040 |
Why?
|
Phospholipids | 1 | 2019 | 177 | 0.040 |
Why?
|
Paranasal Sinuses | 1 | 2019 | 61 | 0.040 |
Why?
|
Primary Cell Culture | 1 | 2019 | 208 | 0.040 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 203 | 0.040 |
Why?
|
Chemokine CXCL10 | 2 | 2011 | 105 | 0.040 |
Why?
|
Macaca mulatta | 1 | 2020 | 717 | 0.040 |
Why?
|
Smokers | 1 | 2019 | 143 | 0.040 |
Why?
|
Genes, T-Cell Receptor delta | 1 | 2017 | 13 | 0.040 |
Why?
|
Programmed Cell Death 1 Ligand 2 Protein | 1 | 2017 | 27 | 0.040 |
Why?
|
Larva | 1 | 2018 | 274 | 0.040 |
Why?
|
Forced Expiratory Volume | 1 | 2019 | 314 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 4938 | 0.040 |
Why?
|
Nicotine | 1 | 2019 | 244 | 0.040 |
Why?
|
Tissue Array Analysis | 1 | 2019 | 760 | 0.040 |
Why?
|
Recombinant Proteins | 3 | 2014 | 2927 | 0.040 |
Why?
|
Prognosis | 2 | 2015 | 21713 | 0.040 |
Why?
|
Smad Proteins | 1 | 2017 | 88 | 0.040 |
Why?
|
Crosses, Genetic | 1 | 1997 | 241 | 0.040 |
Why?
|
Smad4 Protein | 1 | 2018 | 196 | 0.040 |
Why?
|
Proteins | 2 | 2014 | 1963 | 0.040 |
Why?
|
Gene Expression Profiling | 2 | 2019 | 5159 | 0.040 |
Why?
|
Immunotherapy | 1 | 2010 | 3341 | 0.040 |
Why?
|
Treatment Outcome | 1 | 2018 | 32848 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 1997 | 173 | 0.040 |
Why?
|
Melanoma, Experimental | 1 | 2019 | 368 | 0.040 |
Why?
|
Mucous Membrane | 2 | 2013 | 271 | 0.040 |
Why?
|
Hydrostatic Pressure | 1 | 1996 | 13 | 0.040 |
Why?
|
Pneumonia, Bacterial | 1 | 1997 | 130 | 0.030 |
Why?
|
Phosphorylation | 2 | 2015 | 4804 | 0.030 |
Why?
|
Immunoglobulin Isotypes | 1 | 1996 | 36 | 0.030 |
Why?
|
beta 2-Microglobulin | 1 | 1996 | 184 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 1077 | 0.030 |
Why?
|
Pseudomonas Infections | 1 | 1997 | 156 | 0.030 |
Why?
|
Receptors, Interleukin-3 | 1 | 2015 | 26 | 0.030 |
Why?
|
Pulmonary Ventilation | 1 | 1996 | 45 | 0.030 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2017 | 229 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2018 | 7548 | 0.030 |
Why?
|
Rats | 2 | 2015 | 6086 | 0.030 |
Why?
|
Phagocytes | 1 | 2015 | 44 | 0.030 |
Why?
|
Acetylcholine | 1 | 1996 | 96 | 0.030 |
Why?
|
Antigens | 1 | 1996 | 292 | 0.030 |
Why?
|
Granzymes | 1 | 2015 | 91 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2006 | 2819 | 0.030 |
Why?
|
Colitis | 1 | 2019 | 340 | 0.030 |
Why?
|
Up-Regulation | 1 | 2002 | 2450 | 0.030 |
Why?
|
Trophoblasts | 1 | 1996 | 138 | 0.030 |
Why?
|
Porosity | 1 | 2015 | 56 | 0.030 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2015 | 68 | 0.030 |
Why?
|
Abatacept | 1 | 1994 | 26 | 0.030 |
Why?
|
Child | 2 | 2022 | 29154 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2019 | 1489 | 0.030 |
Why?
|
Autocrine Communication | 1 | 2014 | 84 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 2015 | 328 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2018 | 554 | 0.030 |
Why?
|
Complement C3 | 1 | 2014 | 78 | 0.030 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 243 | 0.030 |
Why?
|
Complement Activation | 1 | 2014 | 94 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2007 | 2195 | 0.030 |
Why?
|
Prodrugs | 1 | 2015 | 217 | 0.030 |
Why?
|
Therapeutic Irrigation | 1 | 2014 | 90 | 0.030 |
Why?
|
Paracrine Communication | 1 | 2014 | 128 | 0.030 |
Why?
|
Rats, Inbred F344 | 1 | 2014 | 224 | 0.030 |
Why?
|
Alveolar Epithelial Cells | 1 | 2014 | 46 | 0.030 |
Why?
|
Vaccination | 1 | 2020 | 1123 | 0.030 |
Why?
|
Potassium Channel Blockers | 1 | 2014 | 110 | 0.030 |
Why?
|
Antigens, Differentiation | 1 | 1994 | 238 | 0.030 |
Why?
|
Down-Regulation | 1 | 2019 | 2074 | 0.030 |
Why?
|
Bronchoconstrictor Agents | 2 | 2003 | 16 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 376 | 0.030 |
Why?
|
Inflammasomes | 1 | 2015 | 161 | 0.030 |
Why?
|
Methacholine Chloride | 2 | 2003 | 29 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 460 | 0.030 |
Why?
|
Receptors, Interleukin-13 | 2 | 2006 | 10 | 0.030 |
Why?
|
Interleukin-12 | 1 | 1994 | 253 | 0.030 |
Why?
|
Interleukin-13 Receptor alpha1 Subunit | 2 | 2006 | 15 | 0.030 |
Why?
|
Hospitalization | 1 | 2022 | 2083 | 0.030 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2015 | 221 | 0.030 |
Why?
|
Histocytochemistry | 1 | 2013 | 185 | 0.030 |
Why?
|
Obesity | 1 | 2005 | 2884 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 992 | 0.030 |
Why?
|
Prospective Studies | 2 | 2022 | 12873 | 0.030 |
Why?
|
Proteolysis | 1 | 2014 | 370 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2018 | 986 | 0.030 |
Why?
|
Immunization | 1 | 2014 | 397 | 0.030 |
Why?
|
Antigens, CD1 | 1 | 2012 | 49 | 0.030 |
Why?
|
Cell Cycle | 1 | 2018 | 2084 | 0.030 |
Why?
|
Chitinases | 1 | 2011 | 4 | 0.030 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2014 | 242 | 0.030 |
Why?
|
Immunoblotting | 1 | 2013 | 886 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2015 | 1070 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2015 | 1338 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2015 | 2307 | 0.020 |
Why?
|
RNA Interference | 1 | 2015 | 1408 | 0.020 |
Why?
|
Chemokine CCL5 | 1 | 2011 | 71 | 0.020 |
Why?
|
Models, Molecular | 1 | 2015 | 1732 | 0.020 |
Why?
|
CTLA-4 Antigen | 1 | 1994 | 657 | 0.020 |
Why?
|
Cholinergic Antagonists | 1 | 2010 | 58 | 0.020 |
Why?
|
Transfection | 1 | 2015 | 2944 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2015 | 1945 | 0.020 |
Why?
|
Cyclosporine | 1 | 2010 | 278 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2015 | 1016 | 0.020 |
Why?
|
Apoptosis | 1 | 2004 | 7591 | 0.020 |
Why?
|
Antigens, CD | 1 | 1994 | 1385 | 0.020 |
Why?
|
Cancer Vaccines | 1 | 2015 | 697 | 0.020 |
Why?
|
Cell Survival | 1 | 2015 | 3045 | 0.020 |
Why?
|
Retinal Dehydrogenase | 1 | 2009 | 91 | 0.020 |
Why?
|
Deoxyuracil Nucleotides | 1 | 2008 | 11 | 0.020 |
Why?
|
RNA Nucleotidyltransferases | 1 | 2008 | 39 | 0.020 |
Why?
|
RNA, Small Untranslated | 1 | 2008 | 29 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 1439 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2015 | 1506 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 2009 | 221 | 0.020 |
Why?
|
Lipopolysaccharide Receptors | 1 | 2008 | 86 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2015 | 2054 | 0.020 |
Why?
|
RNA Stability | 1 | 2008 | 125 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 5112 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2009 | 548 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2014 | 2508 | 0.020 |
Why?
|
Nucleic Acid Conformation | 1 | 2008 | 279 | 0.020 |
Why?
|
Calgranulin A | 1 | 2006 | 12 | 0.020 |
Why?
|
Genomics | 1 | 2018 | 2738 | 0.020 |
Why?
|
Receptors, Leukotriene | 1 | 2006 | 7 | 0.020 |
Why?
|
Hydrolysis | 1 | 2006 | 227 | 0.020 |
Why?
|
S100 Proteins | 1 | 2006 | 181 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2011 | 987 | 0.020 |
Why?
|
Young Adult | 2 | 2015 | 21445 | 0.020 |
Why?
|
Age Factors | 1 | 2015 | 5377 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2006 | 549 | 0.020 |
Why?
|
3T3 Cells | 1 | 2005 | 355 | 0.020 |
Why?
|
Receptor, ErbB-2 | 1 | 2015 | 2518 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2008 | 741 | 0.020 |
Why?
|
Receptors, CXCR3 | 1 | 2004 | 36 | 0.020 |
Why?
|
Time Factors | 2 | 2015 | 12926 | 0.020 |
Why?
|
Lymphocyte Subsets | 1 | 2004 | 137 | 0.020 |
Why?
|
Receptors, Chemokine | 1 | 2004 | 114 | 0.020 |
Why?
|
Chemokines, CXC | 1 | 2004 | 117 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 1375 | 0.020 |
Why?
|
Species Specificity | 1 | 2005 | 777 | 0.020 |
Why?
|
Culture Techniques | 1 | 2003 | 132 | 0.010 |
Why?
|
Free Radicals | 1 | 2003 | 62 | 0.010 |
Why?
|
NF-KappaB Inhibitor alpha | 1 | 2003 | 136 | 0.010 |
Why?
|
Adipocytes | 1 | 2005 | 305 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2003 | 293 | 0.010 |
Why?
|
Lung Compliance | 1 | 2003 | 25 | 0.010 |
Why?
|
I-kappa B Proteins | 1 | 2003 | 170 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 2003 | 311 | 0.010 |
Why?
|
DNA Primers | 2 | 1996 | 1399 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2018 | 13658 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 3639 | 0.010 |
Why?
|
Body Composition | 1 | 2005 | 595 | 0.010 |
Why?
|
I-kappa B Kinase | 1 | 2003 | 250 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2011 | 4892 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2011 | 7551 | 0.010 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2003 | 334 | 0.010 |
Why?
|
Membrane Transport Proteins | 1 | 2003 | 244 | 0.010 |
Why?
|
Metabolic Syndrome | 1 | 2005 | 353 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 2002 | 260 | 0.010 |
Why?
|
Weight Loss | 1 | 2005 | 627 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6207 | 0.010 |
Why?
|
Mice, Inbred A | 1 | 2000 | 33 | 0.010 |
Why?
|
Mice, Congenic | 1 | 2000 | 30 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2005 | 769 | 0.010 |
Why?
|
Mast Cells | 1 | 2002 | 223 | 0.010 |
Why?
|
Nebulizers and Vaporizers | 1 | 2000 | 70 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2003 | 1764 | 0.010 |
Why?
|
Aerosols | 1 | 2000 | 158 | 0.010 |
Why?
|
Basement Membrane | 1 | 2000 | 138 | 0.010 |
Why?
|
Lymphocyte Depletion | 1 | 2000 | 264 | 0.010 |
Why?
|
Muscle Contraction | 1 | 2000 | 218 | 0.010 |
Why?
|
Models, Biological | 1 | 2008 | 3254 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 2000 | 236 | 0.010 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 1998 | 47 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 31252 | 0.010 |
Why?
|
Cell Membrane | 1 | 2002 | 850 | 0.010 |
Why?
|
Constriction, Pathologic | 1 | 2000 | 310 | 0.010 |
Why?
|
Edema | 1 | 2000 | 267 | 0.010 |
Why?
|
Body Mass Index | 1 | 2005 | 2203 | 0.010 |
Why?
|
Diet | 1 | 2005 | 1440 | 0.010 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 1998 | 259 | 0.010 |
Why?
|
Epithelium | 1 | 2000 | 720 | 0.010 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 1996 | 11 | 0.010 |
Why?
|
Strongylida Infections | 1 | 1996 | 15 | 0.010 |
Why?
|
Hemocyanins | 1 | 1996 | 50 | 0.010 |
Why?
|
Antigens, Ly | 1 | 1996 | 49 | 0.010 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 1996 | 88 | 0.010 |
Why?
|
Schistosomiasis mansoni | 1 | 1996 | 30 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1996 | 418 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2000 | 943 | 0.010 |
Why?
|
Lectins, C-Type | 1 | 1996 | 162 | 0.010 |
Why?
|
Antigens, Surface | 1 | 1996 | 295 | 0.010 |
Why?
|
Trans-Activators | 1 | 2002 | 1555 | 0.010 |
Why?
|
Immunoglobulin D | 1 | 1994 | 16 | 0.010 |
Why?
|
DNA | 1 | 2003 | 2693 | 0.010 |
Why?
|
Granuloma | 1 | 1996 | 154 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2010 | 14889 | 0.010 |
Why?
|
Electrophoresis, Agar Gel | 1 | 1993 | 82 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2013 | 29902 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1993 | 300 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 1998 | 1555 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1993 | 5395 | 0.000 |
Why?
|
Lymph Nodes | 1 | 1994 | 2967 | 0.000 |
Why?
|
Risk Factors | 1 | 2000 | 17523 | 0.000 |
Why?
|